Japanese boy with muscular dystrophy to see shuttle launch

Japanese boy with muscular dystrophy to see shuttle launch

OSAKA, Japan - Tadashi Ishizu, a 14-year-old Japanese boy suffering from muscular dystrophy, prepares to leave Osaka airport Oct. 3 for the United States to realize his dream of seeing a space-shuttle launch. Ishizu will join spectators at Florida's Kennedy Space Center to witness the launch of the shuttle Discovery on Oct. 5 (Oct. 6 Japan time), according to the Japan chapter of the U.S.-based Make-A-Wish Foundation, which arranged the trip after it was contacted by Ishizu.

Embryo biopsy approved in Japan

Embryo biopsy approved in Japan

The photo shows Kagoshima University's medical hospital, where an ethics panel approved Jan. 28 the conditional practice of a testing method for hereditary diseases called embryo biopsy. It is the first medical institution in Japan to do so. The approval, which applies particularly to tests for Duchenne muscular dystrophy in newly fertilized eggs, could lead to the first application of the technique in a few months.

Esports competition for disabled

Esports competition for disabled

Japanese esports player Ryuya Koshizuka, a 31-year-old muscular dystrophy patient, practices in Gunma Prefecture's Isesaki, eastern Japan, on June 10, 2019, for a gaming competition for the disabled being held on Aug. 31 in Takasaki in the same prefecture. (Kyodo) ==Kyodo

Japanese boy with muscular dystrophy to see shuttle launch

Japanese boy with muscular dystrophy to see shuttle launch

OSAKA, Japan - Tadashi Ishizu, a 14-year-old Japanese boy suffering from muscular dystrophy, prepares to leave Osaka airport Oct. 3 for the United States to realize his dream of seeing a space-shuttle launch. Ishizu will join spectators at Florida's Kennedy Space Center to witness the launch of the shuttle Discovery on Oct. 5 (Oct. 6 Japan time), according to the Japan chapter of the U.S.-based Make-A-Wish Foundation, which arranged the trip after it was contacted by Ishizu.

Embryo biopsy approved in Japan

Embryo biopsy approved in Japan

The photo shows Kagoshima University's medical hospital, where an ethics panel approved Jan. 28 the conditional practice of a testing method for hereditary diseases called embryo biopsy. It is the first medical institution in Japan to do so. The approval, which applies particularly to tests for Duchenne muscular dystrophy in newly fertilized eggs, could lead to the first application of the technique in a few months. ==Kyodo